Theranostic Advances in Breast Cancer in Nuclear Medicine

The implication of ‘theranostic’ refers to targeting an identical receptor for diagnostic and therapeutic purposes, by the same radioligand, simultaneously or separately. In regard to extensive efforts, many considerable theranostic tracers have been developed in recent years. Emerging evidence stro...

Full description

Bibliographic Details
Main Authors: Nasim Vahidfar, Ayuob Aghanejad, Hojjat Ahmadzadehfar, Saeed Farzanehfar, Elisabeth Eppard
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/9/4597
id doaj-09c984df5f2f4563a1f5991ef6dc5902
record_format Article
spelling doaj-09c984df5f2f4563a1f5991ef6dc59022021-04-27T23:05:35ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-04-01224597459710.3390/ijms22094597Theranostic Advances in Breast Cancer in Nuclear MedicineNasim Vahidfar0Ayuob Aghanejad1Hojjat Ahmadzadehfar2Saeed Farzanehfar3Elisabeth Eppard4Department of Nuclear Medicine, Vali-Asr Hospital, Tehran University of Medical Sciences, Tehran 1419733141, IranResearch Center for Pharmaceutical Nanotechnology, Biomedicine Institute, Tabriz University of Medical Sciences, Tabriz 51368, IranDepartment of Nuclear Medicine, Klinikum Westfalen, 44149 Dortmund, GermanyDepartment of Nuclear Medicine, Vali-Asr Hospital, Tehran University of Medical Sciences, Tehran 1419733141, IranPositronpharma SA. Rancagua 878, Santiago 7500621, ChileThe implication of ‘theranostic’ refers to targeting an identical receptor for diagnostic and therapeutic purposes, by the same radioligand, simultaneously or separately. In regard to extensive efforts, many considerable theranostic tracers have been developed in recent years. Emerging evidence strongly demonstrates the tendency of nuclear medicine towards therapies based on a diagnosis. This review is focused on the examples of targeted radiopharmaceuticals for the imaging and therapy of breast cancer.https://www.mdpi.com/1422-0067/22/9/4597theranosticradiopharmaceuticalimagingtherapy
collection DOAJ
language English
format Article
sources DOAJ
author Nasim Vahidfar
Ayuob Aghanejad
Hojjat Ahmadzadehfar
Saeed Farzanehfar
Elisabeth Eppard
spellingShingle Nasim Vahidfar
Ayuob Aghanejad
Hojjat Ahmadzadehfar
Saeed Farzanehfar
Elisabeth Eppard
Theranostic Advances in Breast Cancer in Nuclear Medicine
International Journal of Molecular Sciences
theranostic
radiopharmaceutical
imaging
therapy
author_facet Nasim Vahidfar
Ayuob Aghanejad
Hojjat Ahmadzadehfar
Saeed Farzanehfar
Elisabeth Eppard
author_sort Nasim Vahidfar
title Theranostic Advances in Breast Cancer in Nuclear Medicine
title_short Theranostic Advances in Breast Cancer in Nuclear Medicine
title_full Theranostic Advances in Breast Cancer in Nuclear Medicine
title_fullStr Theranostic Advances in Breast Cancer in Nuclear Medicine
title_full_unstemmed Theranostic Advances in Breast Cancer in Nuclear Medicine
title_sort theranostic advances in breast cancer in nuclear medicine
publisher MDPI AG
series International Journal of Molecular Sciences
issn 1661-6596
1422-0067
publishDate 2021-04-01
description The implication of ‘theranostic’ refers to targeting an identical receptor for diagnostic and therapeutic purposes, by the same radioligand, simultaneously or separately. In regard to extensive efforts, many considerable theranostic tracers have been developed in recent years. Emerging evidence strongly demonstrates the tendency of nuclear medicine towards therapies based on a diagnosis. This review is focused on the examples of targeted radiopharmaceuticals for the imaging and therapy of breast cancer.
topic theranostic
radiopharmaceutical
imaging
therapy
url https://www.mdpi.com/1422-0067/22/9/4597
work_keys_str_mv AT nasimvahidfar theranosticadvancesinbreastcancerinnuclearmedicine
AT ayuobaghanejad theranosticadvancesinbreastcancerinnuclearmedicine
AT hojjatahmadzadehfar theranosticadvancesinbreastcancerinnuclearmedicine
AT saeedfarzanehfar theranosticadvancesinbreastcancerinnuclearmedicine
AT elisabetheppard theranosticadvancesinbreastcancerinnuclearmedicine
_version_ 1721505269188395008